{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:53:36Z","timestamp":1781650416063,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac dysfunction is common in septic shock and may be influenced by intravenous (IV) fluid therapy. We aimed to investigate the effects of restrictive versus standard IV fluid therapy on plasma N-terminal pro B-type natriuretic peptide (NTproBNP), a marker of cardiac dysfunction, in adult intensive care unit (ICU) patients with septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective exploratory sub-study of the randomised CLASSIC trial enrolled adult ICU patients with septic shock at one Danish and one Swedish ICU between February 2020 and October 2021. Patients were randomised to restrictive versus standard IV fluid therapy. Plasma NTproBNP was measured at randomisation (T0), the following morning (T1), the morning after (T2), and at ICU discharge or day 90 (T3). The exploratory outcome was the between-group difference in NTproBNP across timepoints assessed using mixed models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-four patients were included. NTproBNP levels did not differ significantly between groups at any timepoint. At T1, mean NTproBNP levels were 7667 ng\/L in the restrictive group and 8913 ng\/L in the standard group, with an estimated between-group difference of -1245 (95% CI -4065\u20131575). Similarly, no statistically significant differences were observed at T2 and T3. No group-by-time interaction was observed (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.925).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No statistically significant difference in plasma NTproBNP between adult ICU patients with septic shock randomised to restrictive versus standard IV fluid therapy was seen. Uniformly elevated levels could suggest that NTproBNP in septic shock primarily reflects systemic inflammation rather than fluid-induced cardiac loading. Results should be interpreted with caution due to the small sample size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT04282252. Registered 31 January 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-026-03836-6","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:28:28Z","timestamp":1776252508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Restrictive versus standard intravenous fluid therapy and NTproBNP in ICU patients with septic shock \u2013 a sub-study of the randomised CLASSIC trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Jens","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praleene","family":"Sivapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Sylvest","family":"Meyhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"J\u00e4rnbert-Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Hylander","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theis","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Buhl","family":"Hjortrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Joelsson-Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Jonmarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric","family":"Sj\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H\u00e5kansson","family":"Gladh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cronhjort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"21","key":"3836_CR1","first-page":"2063","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(21):2063.","journal-title":"N Engl J Med"},{"issue":"17","key":"3836_CR2","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1001\/jama.2024.3917","volume":"331","author":"S Iyer","year":"2024","unstructured":"Iyer S, Kennedy JN, Jentzer JC, Senussi MH, Seymour CW. Cardiac Function Before Sepsis and Clinical Outcomes. JAMA. 2024;331(17):1496\u20139.","journal-title":"JAMA"},{"issue":"1","key":"3836_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jointm.2021.11.004","volume":"2","author":"F Boissier","year":"2022","unstructured":"Boissier F, Aissaoui N. Septic cardiomyopathy: Diagnosis and management. J Intensive Med. 2022;2(1):8\u201316.","journal-title":"J Intensive Med"},{"key":"3836_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","volume":"4","author":"Y Kakihana","year":"2016","unstructured":"Kakihana Y, Ito T, Nakahara M, Yamaguchi K, Yasuda T. Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care. 2016;4:22.","journal-title":"J Intensive Care"},{"issue":"9","key":"3836_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/08850666231180526","volume":"38","author":"D Hasegawa","year":"2023","unstructured":"Hasegawa D, Ishisaka Y, Maeda T, Prasitlumkum N, Nishida K, Dugar S, Sato R. Prevalence and Prognosis of Sepsis-Induced Cardiomyopathy: A Systematic Review and Meta-Analysis. J Intensive Care Med. 2023;38(9):797\u2013808.","journal-title":"J Intensive Care Med"},{"key":"3836_CR6","doi-asserted-by":"publisher","unstructured":"Prescott HC, Antonelli M, Alhazzani W, Moller MH, Alshamsi F, Azevedo LCP et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026. https:\/\/doi.org\/10.1097\/CCM.0000000000007075.","DOI":"10.1097\/CCM.0000000000007075"},{"key":"3836_CR7","unstructured":"Delicce AV, Makaryus AN. Physiology, Frank Starling Law. StatPearls. Treasure Island (FL). 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470295\/."},{"issue":"Suppl 1","key":"3836_CR8","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.21037\/jtd.2019.12.84","volume":"12","author":"PE Marik","year":"2020","unstructured":"Marik PE, Byrne L, van Haren F. Fluid resuscitation in sepsis: the great 30 mL per kg hoax. J Thorac Dis. 2020;12(Suppl 1):S37\u201347.","journal-title":"J Thorac Dis"},{"issue":"7","key":"3836_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hernandez","year":"2019","unstructured":"Hernandez G, Ospina-Tascon GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019;321(7):654\u201364.","journal-title":"JAMA"},{"key":"3836_CR10","doi-asserted-by":"publisher","first-page":"131144","DOI":"10.1016\/j.ijcard.2023.131144","volume":"387","author":"Z Ma","year":"2023","unstructured":"Ma Z, Krishnamurthy M, Modi V, Allen D, Shirani J. Impact of cardiac troponin release and fluid resuscitation on outcomes of patients with sepsis. Int J Cardiol. 2023;387:131144.","journal-title":"Int J Cardiol"},{"issue":"9380","key":"3836_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","volume":"362","author":"JA de Lemos","year":"2003","unstructured":"de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362(9380):316\u201322.","journal-title":"Lancet"},{"issue":"13","key":"3836_CR12","first-page":"e356","volume":"115","author":"DA Morrow","year":"2007","unstructured":"Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356\u201375.","journal-title":"Circulation"},{"issue":"3","key":"3836_CR13","doi-asserted-by":"publisher","first-page":"e6549","DOI":"10.1016\/j.jcrc.2014.12.008","volume":"30","author":"H Cheng","year":"2015","unstructured":"Cheng H, Fan WZ, Wang SC, Liu ZH, Zang HL, Wang LZ, et al. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study. J Crit Care. 2015;30(3):e6549\u201314.","journal-title":"J Crit Care"},{"issue":"5","key":"3836_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/01.CCM.0000261893.72811.0F","volume":"35","author":"M Varpula","year":"2007","unstructured":"Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettila V, Group FS. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med. 2007;35(5):1277\u201383.","journal-title":"Crit Care Med"},{"issue":"1","key":"3836_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13054-018-2043-8","volume":"22","author":"RR Ehrman","year":"2018","unstructured":"Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, Levy PD. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 2018;22(1):112.","journal-title":"Crit Care"},{"issue":"7","key":"3836_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurheartj\/ehr351","volume":"33","author":"G Landesberg","year":"2012","unstructured":"Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J. 2012;33(7):895\u2013903.","journal-title":"Eur Heart J"},{"key":"3836_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcme.2016.01.002","volume":"10","author":"AB Groeneveld","year":"2016","unstructured":"Groeneveld AB. J. TRJ. N-terminal-pro-brain natriuretic peptide elevations in the course of septic and non-septic shock reflect systolic left ventricular dysfunction assessed by transpulmonary thermodilution. IJC Metabolic Endocr. 2016;10:30\u20135.","journal-title":"IJC Metabolic Endocr"},{"issue":"4","key":"3836_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/CCM.0000000000001473","volume":"44","author":"S Masson","year":"2016","unstructured":"Masson S, Caironi P, Fanizza C, Carrer S, Caricato A, Fassini P, et al. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock. Crit Care Med. 2016;44(4):707\u201316.","journal-title":"Crit Care Med"},{"key":"3836_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1757-7241-20-86","volume":"20","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang Z, Xue Y, Xu X, Ni H. Prognostic value of B-type natriuretic peptide (BNP) and its potential role in guiding fluid therapy in critically ill septic patients. Scand J Trauma Resusc Emerg Med. 2012;20:86.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"26","key":"3836_CR20","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","volume":"386","author":"TS Meyhoff","year":"2022","unstructured":"Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med. 2022;386(26):2459\u201370.","journal-title":"N Engl J Med"},{"key":"3836_CR21","unstructured":"Christensen J. The Effects Of Restrictive Versus Standard Intravenous Fluid Management On Cardiac Function In ICU Patients With Septic Shock. OSF; 2024. https:\/\/osf.io\/sguj6\/overview."},{"issue":"8","key":"3836_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"9","key":"3836_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/aas.13434","volume":"63","author":"TS Meyhoff","year":"2019","unstructured":"Meyhoff TS, Hjortrup PB, Moller MH, Wetterslev J, Lange T, Kjaer MN, et al. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2019;63(9):1262\u201371.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"11","key":"3836_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3836_CR25","doi-asserted-by":"publisher","first-page":"e70156","DOI":"10.1111\/aas.70156","volume":"70","author":"J Christensen","year":"2026","unstructured":"Christensen J, Sivapalan P, Meyhoff TS, Jarnbert-Pettersson H, Perner A, Moller MH, et al. Restrictive Versus Standard Intravenous Fluid Therapy and Endothelial Glycocalyx Shedding in ICU Patients With Septic Shock-A Preplanned Sub-Study of the Randomized CLASSIC Trial. Acta Anaesthesiol Scand. 2026;70(1):e70156.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"3836_CR26","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/cc5721","volume":"11","author":"D Mokart","year":"2007","unstructured":"Mokart D, Sannini A, Brun JP, Faucher M, Blaise D, Blache JL, Faucher C. N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock. Crit Care. 2007;11(2):R37.","journal-title":"Crit Care"},{"issue":"1","key":"3836_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2007.03.108","volume":"126","author":"A Rudiger","year":"2008","unstructured":"Rudiger A, Fischler M, Harpes P, Gasser S, Hornemann T, von Eckardstein A, Maggiorini M. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts. Int J Cardiol. 2008;126(1):28\u201331.","journal-title":"Int J Cardiol"},{"issue":"8","key":"3836_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejim.2006.07.013","volume":"17","author":"R Shor","year":"2006","unstructured":"Shor R, Rozenman Y, Bolshinsky A, Harpaz D, Tilis Y, Matas Z, et al. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med. 2006;17(8):536\u201340.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"3836_CR29","doi-asserted-by":"publisher","first-page":"e006570","DOI":"10.1161\/CIRCHEARTFAILURE.119.006570","volume":"13","author":"H Fish-Trotter","year":"2020","unstructured":"Fish-Trotter H, Ferguson JF, Patel N, Arora P, Allen NB, Bachmann KN, et al. Inflammation and Circulating Natriuretic Peptide Levels. Circ Heart Fail. 2020;13(7):e006570.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"3836_CR30","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.chest.2018.04.043","volume":"154","author":"A Protti","year":"2018","unstructured":"Protti A, Masson S, Latini R, Fumagalli R, Romero M, Pessina C, et al. Persistence of Central Venous Oxygen Desaturation During Early Sepsis Is Associated With Higher Mortality: A Retrospective Analysis of the ALBIOS Trial. Chest. 2018;154(6):1291\u2013300.","journal-title":"Chest"},{"issue":"4","key":"3836_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00134-018-5147-3","volume":"44","author":"N Van Regenmortel","year":"2018","unstructured":"Van Regenmortel N, Verbrugghe W, Roelant E, Van den Wyngaert T, Jorens PG. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018;44(4):409\u201317.","journal-title":"Intensive Care Med"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-03836-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-03836-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-03836-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:06:24Z","timestamp":1781647584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-026-03836-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3836"],"URL":"https:\/\/doi.org\/10.1186\/s12871-026-03836-6","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was acquired from the Swedish Ethical Review Authority (2018\/1503\u201331 and 2019\u201301862). The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants or their legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"241"}}